Acute cerebral infarction has rapid onset, rapid development, complex disease, step aggravation, poor prognosis, and lack of safe and effective treatment countermeasures, which has become an urgent problem to be solved clinically. Early and timely administration of acute cerebral infarction and the combination of drugs are the key to treatment. Shuxuining is one of the commonly used Chinese medicine injections in the treatment of acute cerebral infarction. It can be combined with different western medicines to treat acute cerebral infarction to produce good effect, and alleviate the disadvantages of single drug treatment to a certain extent. This paper summarizes the mechanism of shuxuening combined with different western medicines in the treatment of acute cerebral infarction, and provides a new idea for the early combination of acute cerebral infarction and the treatment of integrated Chinese and western medicine.

Yufang Li, Bing Xu. Mechanism of action of Shuxuening combination for acute cerebral infarction. International Journal of Frontiers in Medicine (2023), Vol. 5, Issue 2: 65-70. https://doi.org/10.25236/IJFM.2023.050212.

[1] Jia Jianping. Neurology (8th edition) [M]: Neurology (8th edition), 2018.

[2] Mengnan L, Yuting P, Juan G, et al. Evaluation of Zhilong Huoxue Tongyu Capsule in the Treatment of Acute Cerebral Infarction: A Systematic Review and Meta-analysis of Randomized Controlled Trials[J]. 2021.

[3] Ghaleiha Ali, Haghighi Mohammad, Sharifmehr Mehdi, et al. Oral loading of sodium valproate compared to intravenous loading and oral maintenance in acutely manic bipolar patients.[J]. Neuropsychobiology, 2014, 70(1).

[4] Hao Yawen. Progress in the treatment of acute cerebral infarction [J]. Tianjin Pharmacy, 2021,33 (4): 66-69.

[5] Wan Min, Song Xifang, Jia Weihua. Progress in the vascular recanalization of acute cerebral infarction [J]. Stroke and Neurological Diseases, 2021,28 (1): 4.

[6] Yang Yang, Zhou Bin, Zhao Wenjie. Ginkgo biloba history: a model of the research and development of traditional Chinese medicine and botanical medicine [J]. Chinese herbal medicine, 2016.

[7] Liu Lu. Study on quality and chemical composition of Shuxuening Injection [J]. Beijing University of Traditional Chinese Medicine, 2015.

[8] Xu Yanhua, Liu Fangfang, Li Shilin, Ma Tongfu, Wang Libo. Analysis of the clinical efficacy of treatment using Shuxuening injection in patients with acute cerebral infarction [J]. Electronic Journal of Integrated Chinese Medicine and Western Medicine, 2020,8 (23): 2.

[9] Huang Ya, He Tianmai, Han Songjie, et al. Evaluation of the clinical evidence of Shusersunin injection and its effect characteristics [J]. World Science and Technology: Modernization of Traditional Chinese Medicine, 2018, 20 (10): 7.

[10] Wang Qian. Clinical application of Shuxuening injection for treatment of ischemic cerebrovascular disease in the elderly [J]. Chinese Medical Guide, 2018,16 (17): 204-205.

[11] Zhao Lijie, Li Chuanhong. Efficacy and safety of shuserin injection for ischemic cerebrovascular disease in the elderly [J]. Chinese Hospital Drug Evaluation and Analysis, 2018,18 (1): 3.

[12] Huang Zhanshu, Wu Rong. The effect of Shuxuening injection in the early treatment of hypertensive intracerebral hemorrhage [J]. Journal of Ningxia Medical University, 2013 (6): 712-714..

[13] M. Barber, Peter Langhorne, Ann Rumley, et al. Hemostatic function and progressing ischemic stroke: D-dimer predicts early clinical progression.[J]. Stroke, 2004, 35(6): 1421-1425.

[14] Long Jianping, Huang Beitong, Xiong Weimin, et al. Effect of rosuvastatin on MMP-9, and TNF-, in rat models of acute myocardial infarction [J]. Medical clinical Research, 2014,31 (12): 3.

[15] Li Xue, Wang Zengguang. Clinical study of susunine injection combined with atorvastatin for treatment of chronic subdural hematoma in the elderly [J]. Modern Drugs and Clinical, 2017,32 (8): 4.

[16] M.R. Frankel, L.B. Morgenstern, T.Kwiatkowski, et al. Predicting prognosis after stroke: a placebo group analysis from the National Institute of Neurological Disorders and Stroke rt-PA Stroke Trial.[J].Neurology, 2000, 55(7): 952.

[17] Lin Yingkui, Wu Shouxing. Effect of edaravone combined with clopidogrel on inflammatory factors and intracranial blood flow velocity in patients with acute ischemic stroke [J]. Medical Innovation in China, 2019,16 (9): 4.

[18] Zhang Wei, Liu Wei, Wang Ying, et al. Efficacy of subhypothermia combined with edaravone in treating acute cerebral infarction and its effect on serum hs-CRP, NSE, and S100-protein levels [J]. Journal of Integrated Traditional Chinese and Western Medicine, 2019.

[19] Liu Juan, Zhu Jingzhen, Hu Yuming, et al. Meta-analysis of edalavone combined with drainage pass for acute cerebral infarction [J]. Journal of Integrated Traditional Chinese and Western Medicine in Cardiovascular and cerebrovascular Diseases, 2019,17 (4): 6.

[20] Guo Pengpeng. Effect of susersunin injection combined with edaravone on serum IL-6, TNF-levels in patients with acute cerebral infarction [J]. Modern Diagnosis and Therapy, 2021,32 (9): 2.

[21] Cheng Zejun, Wang Wenke, Qiu Zhihong. Effects of Shuxueninge injection combined with edaravone injection on acute cerebral infarction on vascular endothelial cell function [J]. Chinese Chinese Medicine emergency, 2016,25 (8): 1568-1571.

[22] Huang Fang. Analysis of the clinical efficacy of Shuxuening combined with edaravone in patients with acute cerebral infarction [J]. Modern Diagnosis and Therapy, 2021,32 (4): 2.

[23] Yang Li. Effect of edaravone combined with suxenin injection on acute cerebral infarction [J]. China Pharmaceutical Herald, 2018,15 (11): 4.

[24] Yang Hongmei, Chang Yinbo, Dynasty, et al. Clinical effect of Edaravone and Shuxuening in the treatment of hemorrhagic cerebral infarction [J]. Clinical Medicine Research and Practice, 2019,4 (33): 2.

[25] Duan Haiyu, Li Qian, Liu Xindong. Effect of rosuvastatin on serum mTOR, Tau protein levels, and neurological deficits in patients with acute cerebral infarction [J]. Journal of Clinical and Experimental Medicine, 2020,19 (17): 4.

[26] Zhang Yunshu. Analysis of the effects of three lipid-lowering drugs on the treatment effect and serum lipid levels in elderly patients with acute cerebral infarction [J]. Chinese Journal of Evidence-based Cardiovascular Medicine, 2016,8 (2): 213-216.

[27], Yang Fan. Effect of rosuvastatin before and after intravenous thrombolysis on neurological function and prognosis in patients with acute cerebral infarction [J]. Guizhou Medicine, 2020,44 (2): 3.

[28] A Koichiro Fujisue, Takuhiro Shirakawa B, C Shinichi Nakamura, et al. Dose-dependent INhibitory effect of rosuVastatin In Japanese patienTs with Acute myocardial infarcTION on serum concentration of matrix metalloproteinases – INVITATION trial - ScienceDirect[J]. Journal of Cardiology, 2018, 72(4): 350-355.

[29] Li Meijie, Yao Lina, Ji Lili, et al. The value of probucol and rosuvastatin for treating carotid atherosclerotic plaque in patients with cerebral infarction combined with diabetes mellitus [J]. Journal of Modern Integrated Traditional Chinese and Western Medicine, 2018,27 (26): 4.

[30] Yin Jian, Yang Songwei, Zhang Wei. Analysis of the clinical efficacy of the different doses of rosuvastatin and a recombinant human tissue plasminogen activator therapy in acute cerebral infarction [J]. Guizhou Medicine, 2019,43 (6): 2.

[31] Wang Yudong. Application of susunin injection and rosuvastatin in patients with acute cerebral infarction [J]. Pharmaceutical Forum Magazine, 2021,42 (5): 5.

[32] Zhang Zhiling, Liu Yumei, Chen Rongfang. Observation of the effect of naloxone combined with early intervention in neonatal asphyxia [J]. The Journal of Nursing, 2004.

[33] Huang Rong'e, Zhang Xuechuan. Changes in serum and peptixeptinin, NT-proBNP levels in patients with acute cerebral infarction and their clinical significance [J]. Chinese Experimental Diagnostics, 2016,20 (3): 4.

[34] Shen Zhichun, Wang Lingfang. Clinical observation of naloxone combined with Shuxuening for acute cerebral infarction [J]. Ningxia Medical Journal, 2010,32 (7): 2.

[35] Feng Xiaofang. Observation of the effect of naloxone and Shuxuening injection [J]. Community Medicine Journal, 2011,9 (1): 1.